- Home
- / Hugel
Hugel
Stock Price
₩265 K
2024-10-28
Market Capitalization
₩3 T
2024-10-28
Revenue
₩425.1 B
FY, 2025
Hugel Summary
Company Summary
- Overview
- Hugel (휴젤) is a bio-pharmaceutical company specializing in medical aesthetic solutions. It offers botulinum toxin, hyaluronic acid fillers, skin boosters, barbed PDO threads, and clinical derma cosmetics.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Chuncheon, KR | view all locations
- Website
- https://www.hugel-inc.com/en
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Moon Hyoungjin, Representative Executive Officer
LocationsView all
2 locations detected
Chuncheon, Gangwon-do HQ
Korea (Republic of)
23 Geodudanji 1-gil, Dongnae-myeon
Seoul
Korea (Republic of)
4f, 17 Samseong-ro 133-gil, Cheongdam-dong, Gangnam-gu
Hugel Financials
Summary Financials
- Revenue (FY, 2025)
- ₩425.1B
- Gross profit (FY, 2025)
- ₩343.0B
- Net income (FY, 2025)
- ₩147.0B
- Cash (FY, 2025)
- ₩209.7B
- EBIT (FY, 2025)
- ₩188.9B
- Enterprise value
- $2.8T